Uveitis News and Research

RSS
Uveitis is an inflammation of the uvea. The uvea is the front part of the eye. It includes the iris, which is the colored part of the eye, and the parts right next to and behind the iris. Uveitis may hurt a lot of parts of the eye. It may last as long as six weeks, or it may last a shorter time.
New RNAi treatment safely blocks ocular inflammation in mice

New RNAi treatment safely blocks ocular inflammation in mice

UC San Diego researchers receive CIRM grants to advance studies on Zika virus and cancer

UC San Diego researchers receive CIRM grants to advance studies on Zika virus and cancer

Researchers uncover two factors that play crucial role in chronic autoimmune disorders

Researchers uncover two factors that play crucial role in chronic autoimmune disorders

New partnership-funded research could lead to better treatment for birdshot

New partnership-funded research could lead to better treatment for birdshot

Patients with noninfectious uveitis can get effective treatment from corticosteroid alternative

Patients with noninfectious uveitis can get effective treatment from corticosteroid alternative

Researchers find genomic material from Zika virus in tears

Researchers find genomic material from Zika virus in tears

New study shows Ebola survivors may be at risk of severe vision loss

New study shows Ebola survivors may be at risk of severe vision loss

Physician-researchers find link between 'dry eye' and chronic pain syndromes

Physician-researchers find link between 'dry eye' and chronic pain syndromes

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck announce another immuno-oncology collaboration

Lilly, Merck expand oncology clinical trial collaboration

Lilly, Merck expand oncology clinical trial collaboration

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

TxCell reviews its manufacturing strategy to focus on R&D and strategic partnerships - its core, high added value businesses

FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis

FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis

NEI experts explore long-term effects of Ebola on the eye

NEI experts explore long-term effects of Ebola on the eye

Global urinary catheters market to expand at 4.1% CAGR between 2015 and 2021

Global urinary catheters market to expand at 4.1% CAGR between 2015 and 2021

Bacteria in gut may be the cause of uveitis in the eye

Bacteria in gut may be the cause of uveitis in the eye

New study suggests novel ways to treat serous retinal detachment

New study suggests novel ways to treat serous retinal detachment

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

OphthaliX updates website to reflect proposed acquisition of Israel-based Improved Vision Systems

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Apitope's ATX-F8-117 granted FDA Orphan Drug Designation for treatment of haemophilia A patients

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

TxCell to deliver two presentations on Col-Treg and Ovasave at ISCT Annual Meeting

TxCell to deliver two presentations on Col-Treg and Ovasave at ISCT Annual Meeting